Clinical Trial Update: An Evaluation of Omega-3 Fatty Acid [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating an omega-3 fatty acid for overweight and obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Omega-3 Fatty Acid (omega-3 fatty acids)

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Overweight and Obesity | Phase 1 | Status: COMPLETED